{
  "id": "peptide",
  "title": "Peptide",
  "lang": "en",
  "source_lang": "en",
  "summary": "A peptide is a chain of amino acid residues linked by peptide bonds, with roles in cellular structure, signaling, immunity, metabolism, and medicine.",
  "category": "science",
  "subcategory": "biology",
  "type": "concept",
  "aliases": [
    "Peptides"
  ],
  "generated_at": "2026-11-02",
  "model": "pro/gpt-6.1-sol",
  "url": "https://aiwiki.page/en/peptide/",
  "translations": {
    "zh-Hans": {
      "url": "https://aiwiki.page/zh/peptide/",
      "json": "https://aiwiki.page/zh/peptide.json"
    }
  },
  "sections": [
    {
      "heading": "",
      "text": "A peptide is a molecule composed of two or more amino acid residues joined principally by peptide bonds. Peptides range from simple dipeptides, containing two residues, to chains comprising dozens or hundreds of residues. The term overlaps with polypeptide and protein: no universal length threshold separates these categories, although “peptide” commonly denotes relatively short chains, whereas “protein” generally denotes a biological macromolecule with an organized structure and function.\n\nPeptides occupy a central position between small-molecule chemistry and the biology of proteins. They serve as hormones, neurotransmitters, antimicrobial agents, toxins, metabolic intermediates, and signals used by the immune system. Some are synthesized directly by ribosomes; others are released from larger precursors or assembled by specialized enzymes. Their properties depend not only on amino acid sequence but also on stereochemistry, cyclization, chemical modifications, and interactions with their surroundings.\n\nPeptide research has helped establish how biological sequence determines molecular function. Chemical synthesis and modern analytical methods now make it possible to prepare, identify, and modify peptides systematically, supporting applications in basic research, diagnostics, drug development, and biomaterials."
    },
    {
      "heading": "Chemical definition, nomenclature, and classification",
      "text": "In an ordinary peptide, the carboxyl group of one amino acid is joined to the amino group of another through an amide linkage. The incorporated amino acids are called residues, reflecting the formal loss of the elements of water when free amino acids are represented as forming a peptide. A linear peptide containing \\(n\\) residues normally has \\(n-1\\) backbone peptide bonds. Biological synthesis, however, does not proceed simply by bringing free amino acids together and eliminating water: it uses activated substrates and coupled chemical reactions.\n\nMost biological peptides consist predominantly of α-amino acids, whose amino and carboxyl groups attach to the same central carbon. Their repeating backbone has the pattern \\(\\mathrm{-N-C_{\\alpha}-C(=O)-}\\), while side chains provide much of their chemical diversity. A conventional linear peptide has an amino terminus, or N-terminus, and a carboxyl terminus, or C-terminus. Sequences are written from N-terminus to C-terminus using three-letter or one-letter amino acid codes. Thus, Gly–Ala–Ser and GAS describe the same three-residue sequence, provided the standard code is intended.\n\nA dipeptide contains two residues, a tripeptide three, and an oligopeptide a relatively small number. Polypeptide emphasizes a longer chain, but usage varies among disciplines. A boundary around 50 residues is sometimes adopted for practical classification, yet it is not a fundamental chemical distinction. Insulin, for example, contains 51 residues distributed between two disulfide-linked chains and is described both as a peptide hormone and as a small protein. Conversely, a long, unstructured synthetic chain may be called a polypeptide without being treated as a conventional protein.\n\nPeptides can also be classified by architecture. Linear peptides possess an open backbone; cyclic peptides contain a covalently closed ring. Branched peptides may involve side-chain amino or carboxyl groups rather than only the α-amino and α-carboxyl groups. Such nonstandard amide connections are called isopeptide bonds. Glutathione, for example, contains a γ-glutamyl linkage formed through the side-chain carboxyl group of glutamate. Depsipeptides contain one or more ester linkages in place of amide linkages.\n\nChemical additions generate further categories, including glycopeptides, lipopeptides, and phosphopeptides. These names indicate attached sugars, lipid groups, or phosphate groups rather than a particular length or biological function. Classification by function—such as hormone, toxin, or antibiotic—therefore intersects with classification by structure and origin. Two peptides of similar size can have entirely different architectures and biological activities, while structurally unrelated peptides may act on the same target."
    },
    {
      "heading": "Bonding, conformation, and physicochemical properties",
      "text": "The peptide bond has distinctive properties because electrons are delocalized between the carbonyl group and the amide nitrogen. This resonance gives the carbon–nitrogen bond partial double-bond character, restricting rotation and making the peptide group approximately planar. Most peptide bonds adopt the trans configuration. Cis configurations occur more frequently when the following residue is proline, although trans remains common even in that context. Interconversion can be slow enough to influence folding and biological activity.\n\nThe principal flexibility of a conventional peptide backbone comes from rotation around bonds on either side of the α-carbon. These rotations are described by the dihedral angles \\(\\phi\\) and \\(\\psi\\). Steric interference between atoms restricts the accessible combinations, a relationship represented in a Ramachandran plot. Sequence therefore constrains conformation even before long-range interactions are considered. Glycine permits unusually broad conformational freedom because its side chain is hydrogen, whereas proline restricts backbone geometry through its ring structure.\n\nBackbone carbonyl oxygens and most backbone amide hydrogens participate in hydrogen bonding. Suitable sequences can form an α-helix, β-sheet, or compact turn. Short peptides often populate several conformations rather than maintaining a single stable fold. Their conformational distribution depends on the solvent, temperature, concentration, and binding partners. A peptide that is disordered in solution may become helical when associated with a membrane or receptor. Consequently, an experimentally determined structure describes a particular molecular environment, not necessarily every condition in which the peptide exists.\n\nCharge depends on terminal groups, ionizable side chains, chemical modifications, and pH. For an isolated acidic group, the fraction in the deprotonated state can be approximated by\n\n\\[f_{\\mathrm{A^-}}=\\frac{1}{1+10^{pK_a-\\mathrm{pH}}}.\\]\n\nWithin a peptide, neighboring charges, solvent exposure, and hydrogen bonding can shift individual \\(pK_a\\) values. A sequence containing several lysine or arginine residues may be strongly cationic near physiological pH, whereas one rich in glutamate or aspartate may be anionic. Charge influences solubility, binding, membrane association, and separation during analysis.\n\nThe hydrophobic effect can promote folding, membrane binding, or aggregation, depending on how nonpolar side chains are arranged. Disulfide bonds between cysteine residues provide additional covalent constraints. Cyclization and the incorporation of D-amino acids can alter both conformational preferences and susceptibility to enzymatic cleavage. Although ribosomal peptides initially contain predominantly L-amino acids, specialized biological pathways and chemical synthesis generate many exceptions. These structural details explain why peptides with identical residue compositions but different sequences, stereochemistry, or cross-links can behave very differently."
    },
    {
      "heading": "Biological synthesis, maturation, and degradation",
      "text": "Most genetically encoded peptides begin with translation on a ribosome. Amino acids are attached to their corresponding transfer RNAs, and the ribosome reads the sequence of codons in messenger RNA. During chain elongation, the growing peptide is transferred from a tRNA to the amino group of the next aminoacyl-tRNA. The catalytic center responsible for peptide-bond formation is largely composed of ribosomal RNA. Chain growth proceeds from the N-terminus toward the C-terminus, with substrate activation ultimately supported by ATP consumption during tRNA charging.\n\nMany biologically active peptides are not translated directly in their final form. They are produced as portions of larger precursor proteins. Secreted peptide hormones commonly originate as preproproteins containing a signal sequence that directs the nascent chain into the endoplasmic reticulum. Removal of that signal sequence produces a proprotein, which may undergo further cleavage and modification during passage through the secretory pathway. Insulin illustrates this sequence: preproinsulin becomes proinsulin, which folds and forms disulfide bonds before processing releases insulin and C-peptide.\n\nProteolytic cleavage is often selective rather than indiscriminate. Specialized enzymes recognize particular sequence contexts, including clusters of basic residues in many prohormones. Additional processing may remove terminal residues, amidate the C-terminus, or convert an N-terminal glutamine or glutamate into pyroglutamate. These modifications can influence receptor binding and resistance to degradation. A single precursor can yield several active products: proopiomelanocortin, for example, gives rise to different peptide hormones in different tissues because the processing enzymes and cellular environments differ.\n\nA separate biosynthetic route uses nonribosomal peptide synthetases. These large, modular enzyme systems activate amino acids and tether intermediates to carrier domains. Successive modules select substrates and form peptide bonds, often incorporating D-amino acids, unusual residues, lipid groups, or cyclic structures. The immunosuppressant cyclosporine and the antibiotic daptomycin are products of nonribosomal biosynthesis. Other natural products begin as ribosomally synthesized precursor peptides but undergo extensive enzymatic modification, generating structures that cannot be inferred from the unmodified sequence alone.\n\nPeptides are continuously removed as well as produced. Proteases cleave internal peptide bonds, while aminopeptidases and carboxypeptidases remove residues from the ends. Degradation controls signal duration, recycles amino acids, and eliminates damaged or unnecessary material. Peptide disappearance from circulation can also involve renal filtration, tissue uptake, and intracellular breakdown. Sequence context and accessibility are critical: a cleavage site buried within a constrained structure may be less susceptible than the same sequence in an extended chain. Thus, biological abundance reflects the balance among synthesis, processing, distribution, and clearance."
    },
    {
      "heading": "Physiological signaling and metabolic functions",
      "text": "Peptide hormones coordinate processes across tissues by binding specific receptors. Insulin, released by pancreatic β cells, acts through a receptor tyrosine kinase to regulate glucose handling and broader anabolic metabolism. Glucagon, a 29-residue peptide released by pancreatic α cells, acts chiefly on the liver to promote glucose production during fasting. Their contrasting actions illustrate how peptide signals participate in integrated regulation rather than operating as isolated switches. Secretion, receptor abundance, intracellular signaling, and feedback all influence the physiological response.\n\nMany shorter peptide signals act through a G protein-coupled receptor. Oxytocin and vasopressin each contain nine residues and a disulfide-linked ring, but differences in sequence and receptor recognition support distinct functions. Oxytocin participates in uterine contraction and milk ejection; vasopressin regulates water balance and can influence vascular tone. Angiotensin II, an eight-residue peptide generated through sequential precursor cleavage, contributes to blood-pressure regulation and aldosterone secretion. These examples also show that peptide activity depends on the enzymes that generate and inactivate the signal.\n\nIn the nervous system, neuropeptides often modulate neuronal activity over broader spatial and temporal scales than rapidly acting small-molecule transmitters. Substance P participates in nociceptive signaling, while endogenous opioid peptides such as enkephalins act at opioid receptors. Peptides are commonly packaged in dense-core secretory vesicles and may be released alongside a conventional neurotransmitter. Their effects depend on receptor subtype, anatomical location, and patterns of release. A peptide can alter membrane excitability, transmitter release, or gene expression without directly opening an ion channel.\n\nPeptides also have intracellular metabolic roles. Glutathione is a tripeptide composed of glutamate, cysteine, and glycine. Its cysteine thiol participates in antioxidant defense and reactions catalyzed by glutathione-dependent enzymes. The reduced and oxidized forms, conventionally written GSH and GSSG, are connected by the half-reaction\n\n\\[2\\,\\mathrm{GSH}\\rightleftharpoons \\mathrm{GSSG}+2\\,\\mathrm{H^+}+2\\,\\mathrm{e^-}.\\]\n\nThe biological behavior of this system depends on concentrations, compartmentation, and enzyme activity, rather than on the equation alone. Glutathione also contributes to the conjugation and processing of various electrophilic compounds.\n\nDietary proteins generate peptides during digestion, and intestinal transporters absorb many dipeptides and tripeptides before intracellular hydrolysis releases their constituent amino acids. Food-derived peptides may also interact with enzymes or receptors in experimental systems. However, activity measured in a purified assay does not by itself establish a physiological effect after ingestion. Digestion, absorption, achievable tissue concentration, and metabolic transformation determine whether an intact sequence can reach a relevant target. This distinction is important when evaluating claims about biologically active peptides in foods."
    },
    {
      "heading": "Immunity, host defense, and ecological interactions",
      "text": "Peptides are central to the recognition of intracellular and extracellular proteins by adaptive immunity. Cells continuously generate peptide fragments through protein degradation. A subset is loaded onto major histocompatibility complex molecules and displayed at the cell surface. A T-cell receptor recognizes the combined surface formed by the peptide and the presenting molecule, rather than generally recognizing a free peptide in solution. Changes in the displayed peptide repertoire can reveal infection, altered cellular proteins, or tissue-specific expression.\n\nMHC class I molecules generally present peptides to CD8 T cells. Many class I-bound peptides contain approximately 8–11 residues, although longer examples occur. Their binding commonly involves anchoring both ends within a groove, with particular side chains fitting allele-specific pockets. MHC class II molecules generally present peptides to CD4 T cells. Their binding groove is open at the ends, allowing longer peptides, often around 13–25 residues, to extend beyond a central binding region. These are characteristic ranges, not absolute limits.\n\nAntigen processing determines which sequences become available for presentation. Cytosolic protein degradation and transport into the endoplasmic reticulum supply many class I ligands, while endosomal and lysosomal processing supplies many class II ligands. Cross-presentation permits certain antigen-presenting cells to display peptides derived from extracellular material on class I molecules. Peptide presentation is also involved in immune tolerance: developing and mature T cells encounter self-derived peptide–MHC complexes through mechanisms that help limit harmful self-reactivity.\n\nAntimicrobial peptides form another major intersection between peptides and immunity. Human defensins and the cathelicidin-derived peptide LL-37 are examples associated with innate immunity. Many antimicrobial peptides are cationic and amphipathic, enabling interaction with microbial surfaces and membranes. Some disrupt membrane organization; others enter cells or interfere with specific molecular targets. Their activity depends strongly on salt concentration, surrounding proteins, membrane composition, and local peptide concentration. Membrane disruption is therefore an important mechanism, but not a universal explanation for antimicrobial peptide action.\n\nPeptides also mediate competition, communication, and predation across ecosystems. Bacteria produce bacteriocins that inhibit other bacteria, and some use peptide signals to regulate population-dependent behaviors. Plants produce peptide defense molecules and developmental signals. Cone snails, spiders, and other venomous animals deploy peptides that act on ion channels or receptors with high specificity. Conotoxins are especially notable for their diverse disulfide-constrained architectures. Such molecules reveal how relatively short sequences can evolve precise molecular recognition, while also providing experimental tools for distinguishing closely related physiological targets."
    },
    {
      "heading": "Chemical synthesis and sequence engineering",
      "text": "The chemical synthesis of peptides requires selective bond formation among molecules containing several potentially reactive groups. Uncontrolled coupling would produce mixtures because an amino acid can react through both its amino and carboxyl groups, while some side chains introduce additional reactive sites. Synthetic methods therefore use temporary protecting groups and activated carboxyl derivatives. The objective is to create the desired amide bond while limiting side reactions, including racemization and unwanted branching. Protection and deprotection conditions must also be compatible with the sequence being assembled.\n\nA decisive development was solid-phase peptide synthesis, introduced by R. Bruce Merrifield in 1963. The growing peptide is attached to an insoluble support, allowing excess reagents and by-products to be removed by washing. In a typical cycle, a temporary amino-protecting group is removed, an activated protected amino acid is coupled, and the support is washed before repetition. Conventional assembly proceeds from the C-terminal residue toward the N-terminus, opposite to the direction of ribosomal chain growth. Final cleavage releases the peptide and usually removes remaining side-chain protecting groups.\n\nTwo major protection strategies use Boc and Fmoc chemistry. Boc groups are removed with acid, whereas Fmoc groups are removed under basic conditions. Fmoc-based synthesis is widely used because the temporary N-terminal protection can be removed under conditions distinct from those used for many side-chain protecting groups and resin cleavage. Nevertheless, no strategy eliminates sequence-specific difficulties. Aggregation on the resin can impede coupling, and certain residues or sequence motifs are prone to side reactions. Reagent choice, solvent, temperature, and support properties all affect product quality.\n\nStepwise synthesis becomes more demanding as chain length increases. If each coupling were independently 99% efficient, the fraction successfully completing 49 coupling steps would be approximately\n\n\\[0.99^{49}\\approx 0.61,\\]\n\neven before cleavage losses and other reactions are considered. This simplified calculation explains why small inefficiencies accumulate. Longer targets can instead be assembled from separately prepared fragments. Native chemical ligation, reported in 1994, joins a peptide thioester with an N-terminal cysteine-containing segment through intermediates that ultimately produce a native amide bond. Related methods broaden the range of accessible junctions.\n\nSequence engineering extends beyond reproducing natural molecules. Cyclization, disulfide formation, backbone N-methylation, D-residue substitution, and covalent helix stabilization can alter conformation and stability. A designed modification may improve resistance to proteases but weaken receptor binding, reduce solubility, or complicate synthesis. Peptide libraries and display technologies allow large numbers of sequences to be screened for binding or activity. The resulting candidates still require independent chemical characterization and functional testing, because enrichment in a screening system does not necessarily establish performance in a different biological setting."
    },
    {
      "heading": "Identification, structural analysis, and research methods",
      "text": "Peptide analysis must distinguish several questions: whether a peptide is present, what its sequence and modifications are, how much is present, and what conformation it adopts. No single method answers all of these equally well. Biological samples contain peptides spanning wide concentration ranges, often accompanied by salts, lipids, proteins, and degradation products. Collection and storage conditions matter because proteases may continue to act after sampling, while oxidation and other chemical changes can create products that were not present in the original specimen.\n\nChromatography is widely used to separate peptide mixtures. Reversed-phase liquid chromatography commonly employs a nonpolar stationary phase and a gradient of increasing organic solvent concentration. Retention depends on the peptide’s interactions with the stationary and mobile phases, not simply on molecular size. Ion-exchange methods separate according to charge-related interactions, while size-exclusion methods separate according to hydrodynamic behavior. Ultraviolet absorption near the peptide-bond absorption region can assist detection, although sensitivity and specificity vary with wavelength and sample composition.\n\nMass spectrometry measures mass-to-charge ratios and is central to modern peptide identification. Electrospray ionization often produces multiply charged peptide ions, enabling molecules of substantial mass to be analyzed within an instrument’s accessible range. Tandem mass spectrometry fragments selected precursor ions and uses the resulting pattern to infer sequence. Collision-based methods frequently generate b- and y-type fragment ions, while electron-based methods produce complementary fragmentation patterns. Sequence assignment may involve comparison with predicted spectra from a sequence database or direct interpretation of fragment relationships.\n\nMass alone does not uniquely identify every peptide. Leucine and isoleucine have the same residue mass, and different sequences can have identical overall compositions. Modification sites may also be ambiguous if the available fragments do not distinguish among possible positions. Database searches therefore require statistical evaluation, including control of false discoveries. Quantitative measurements may use isotope-labeled internal standards to account for variation in extraction, chromatography, and ionization. In proteomics, proteins are often digested into peptides, which serve as measurable proxies for their parent proteins; unique sequence assignment is essential when proteins share peptide sequences.\n\nStructural analysis uses complementary techniques. Nuclear magnetic resonance can reveal atomic environments, intramolecular contacts, and conformational exchange in solution. X-ray crystallography can determine detailed structures of crystalline peptides or peptide–target complexes, while circular dichroism provides information about average secondary-structure tendencies. Binding assays, enzyme assays, and cellular experiments establish activity rather than structure alone. A receptor-binding result, for example, does not by itself show whether a peptide activates, inhibits, or otherwise modulates that receptor. Reliable characterization combines chemical identity, structural evidence, and a clearly defined functional measurement."
    },
    {
      "heading": "Therapeutic applications, delivery, and biomaterials",
      "text": "Peptide therapeutics exploit the ability of amino acid sequences to bind biological targets with high specificity. Insulin entered clinical use in 1922 and established that a peptide-based biological product could replace a deficient physiological signal. Subsequent drugs have included analogues of naturally occurring hormones, inhibitors of enzymes, receptor antagonists, and peptides derived from toxins. These products differ widely in size, structure, route of administration, and duration of action; “peptide drug” describes a chemical family rather than a single pharmacological strategy.\n\nExamples illustrate the range. Octreotide is a cyclic analogue of somatostatin designed to retain selected hormonal effects while lasting longer than the natural peptide. Enfuvirtide is a 36-residue inhibitor of HIV membrane fusion. Ziconotide is a synthetic version of a cone-snail peptide that blocks a specific class of voltage-gated calcium channels. Glucagon-like peptide-1 receptor agonists include engineered peptides whose modifications slow enzymatic inactivation or prolong systemic exposure. Each depends on a defined molecular interaction rather than a general property shared by all peptides.\n\nDelivery is a major constraint. Many peptides are readily degraded in the gastrointestinal tract, cross epithelial barriers poorly, and undergo rapid clearance after entering circulation. Their polar backbones and molecular size often limit passive movement through lipid membranes. Consequently, many established peptide medicines are administered by injection, although successful alternatives exist. Oral semaglutide combines a modified peptide with an absorption-enhancing formulation, demonstrating that oral delivery is possible for particular molecules and formulations without implying that it is straightforward for peptides in general.\n\nChemical and pharmaceutical strategies address different parts of this problem. Lipid attachment can promote association with serum albumin and extend exposure; depot formulations can slow release from an injection site. Cyclization, terminal modification, and selected residue substitutions can reduce proteolysis. These changes may also alter target affinity, distribution, or elimination, so longer persistence is not automatically equivalent to improved clinical performance. Purity and manufacturing consistency are equally important: closely related deletion products, epimers, and oxidized variants may require sensitive analytical methods for detection.\n\nPeptides also function outside conventional systemic drug treatment. Radiolabeled receptor-binding peptides can carry imaging or therapeutic radionuclides to tissues expressing a suitable target. Synthetic peptides are used as assay substrates, research probes, and components of diagnostic tests. In materials science, designed sequences can self-assemble into fibers, gels, or surface coatings through hydrogen bonding, hydrophobic interactions, and electrostatic attraction. Such materials may display cell-binding motifs or respond to enzymatic cleavage. Their properties depend on sequence, assembly conditions, and mechanical organization, linking peptide chemistry to tissue engineering and the study of interactions between cells and artificial surfaces."
    }
  ],
  "links": [
    "molecule",
    "amino-acid",
    "peptide-bond",
    "protein",
    "water",
    "antibiotic",
    "resonance-chemistry",
    "ramachandran-plot",
    "hydrogen-bond",
    "alpha-helix",
    "ph",
    "hydrophobic-effect",
    "translation-biology",
    "ribosome",
    "transfer-rna",
    "messenger-rna",
    "adenosine-triphosphate",
    "endoplasmic-reticulum",
    "protease",
    "neurotransmitter",
    "adaptive-immunity",
    "major-histocompatibility-complex",
    "t-cell-receptor",
    "immune-tolerance",
    "innate-immunity",
    "ion-channel",
    "solid-phase-peptide-synthesis",
    "chromatography",
    "mass-spectrometry",
    "proteomics",
    "nuclear-magnetic-resonance",
    "x-ray-crystallography"
  ],
  "sources": [],
  "license": "https://creativecommons.org/licenses/by/4.0/"
}